What's new

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 64, Status: Authorised

Feb 24, 2025 - 10:43
 0
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 64, Status: Authorised
Read More

Tags:

Previous Article

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phe...

Next Article

EuRIC calls for urgent support till EPR for textiles is in place in EU

Related Posts

EMEA-002762-PIP02-20-M02

EMEA-002762-PIP02-20-M02

Feb 14, 2025  0

Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals Under evaluation, 18/02/2025

Referral: Finasteride- and dutasteride-containing medic...

Feb 18, 2025  0

Summary of opinion: Ixchiq, 27/02/2025 Positive

Summary of opinion: Ixchiq, 27/02/2025 Positive

Feb 28, 2025  0